RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 08, 2024 21:15 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
Volaris Celebrates Frontier Airlines’ Reactivation of the Codeshare Agreement Between Both Airlines
May 08, 2024 21:09 ET
|
Controladora Vuela Compañía de Aviación, S.A.B. de C.V.
MEXICO CITY, May 08, 2024 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC)...
Listing of Exodus Class A Common Stock Delayed by NYSE American
May 08, 2024 21:05 ET
|
Exodus
OMAHA, Neb., May 08, 2024 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (OTCQX: EXOD) (the “Company” or “Exodus”) today announced that it was informed by the NYSE American that the exchange has delayed...
Novotech 发布有关血脂异常和非小细胞肺癌全球临床试验概况的新报告
May 08, 2024 21:03 ET
|
Novotech
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech,一家以亚太地区为中心、具有全球执行能力的领先生物技术临床合同研究组织 (CRO) 于今日发布了关于血脂异常和非小细胞肺癌 (NSCLC) 的最新 2023 年全球临床试验情况报告。 Novotech...
Novotech 发布精准肿瘤学格局白皮书,指出靶向治疗的当前趋势和机遇
May 08, 2024 21:03 ET
|
Novotech
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech 是一家提供全方位服务的全球性临床合同研究组织 (CRO),它与生物技术公司合作,加速各个阶段先进和新颖疗法的开发。其最近发布了一份颇具见地的白皮书,《精准肿瘤学:全球临床试验格局》,为癌症治疗提供最新的研究见解。 Novotech...
ALTIMMUNE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Altimmune, Inc. and Encourages Investors to Contact the Firm
May 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, Compass Minerals, and Malibu Boats and Encourages Investors to Contact the Firm
May 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
ANAVEX ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm
May 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
Eye Tracking Market to Hit Enormous Growth of 25.1% By 2033 | Rising Adoption of Eye-Tracking Technology
May 08, 2024 21:00 ET
|
The Brainy Insights
Newark, May 08, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 428.0 million eye tracking market will reach USD 4018.0 million by 2033. An important factor in the growth of the...
VESTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Vestis Corporation on Behalf of Vestis Stockholders and Encourages Investors to Contact the Firm
May 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Vestis Corporation...